KD Pharma, the German developer of Super Critical Technology—a process used to extract and purify omega 3 concentrates—has finalized an agreement with Nutribiolink, Brooklyn, NY, to commercialize its patented high-grade fish oils in U.S. 
 
“We chose Nutribiolink to represent KD Pharma omega 3 oils in the U.S. not only because of their extensive industry contacts, but also because they have the technical knowledge that is required to promote high grade fish oils” stated Chris Hachey, director of sales and marketing at KD Pharma. 
 
KD Pharma has developed the use of Super Critical Technology, with its dual patented process (kd-pür) for extracting and refining highly purified omega 3s from fish oil, by means of Super Critical CO2 Fluid Extraction (SFE) and Super Critical Fluid Chromatography (SFC). This technology gently extracts omega 3 fatty acids without applying excessive heat (< 120°F) and chemical solvents so that the oils never come into contact with oxygen. According to Peter Lembke, vice president of sales and business development at KD Pharma, “This does not only ensures the protection from oxidation of the product, but also from contamination from micro-organisms that cannot survive in an oxygen-free atmosphere, as well as removing harmful substances such as contaminants, heavy metals, PCBs…etc. ”
 
This patented process is also very selective, allowing higher reproducibility and consistency from batch to batch, and higher selectivity and concentration (up to 99% of EPA and/or DHA), compared to other traditional methods. “That gives our customers the ability to decrease the delivery size for the same daily dosage, or to increase the dosage in the same soft-gel size, both lowering the manufacturing costs,” said Mr. Lembke. 
 
As the omega 3 industry is moving towards higher purity, concentration and quality standards, KD Pharma aims to offer “ultra high omega 3 concentrates, with safe processes and low environmental impact, manufactured in a certified cGMP facility for APIs (Active Pharmaceutical Ingredients), the most stringent standard out there” said Nico Bonne, president of Nutribiolink.